Publications by authors named "Audrey French"

Substance use and depression are prevalent in sexual and gender minorities (SGM), but evidence about their impacts on HIV pre-exposure prophylaxis (PrEP) use is mixed. We assessed these impacts in a US-based cohort of 3,330 young SGM who tested negative for HIV and completed baseline and semiannual assessments on substance use (cocaine, methamphetamine, or heroin), depression, and PrEP use and adherence. We estimated prevalence differences (PDs) to compare baseline and 12-month PrEP use and adherence between participants with and without substance use and depression, separately and jointly.

View Article and Find Full Text PDF
Article Synopsis
  • A study investigated long-term body weight changes in people with HIV (PWH) who switched to antiretroviral therapies containing integrase strand-transfer inhibitors (INSTIs), comparing them with those on non-INSTI therapies and people without HIV (PWOH).
  • The analysis included 3464 participants and revealed that women experienced significantly greater weight gain and increases in hip and thigh circumference after switching to INSTIs compared to men, with women gaining +3.0 kg and men +1.8 kg over 5 years.
  • The findings suggest a 2-fold higher weight change in women versus men following the switch to INSTIs, although the long-term health implications of this difference are still uncertain.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to explore the health outcomes of women with HIV who have low-level viremia (LLV), focusing on virologic failure and the development of non-AIDS comorbidities.
  • Researchers analyzed data from the Women's Interagency HIV Study, categorizing women based on their viral load status into groups: virologic suppression, intermittent LLV, persistent LLV, and virologic failure.
  • Results indicated that women with intermittent or persistent LLV had a higher risk of virologic failure compared to those with virologic suppression, with persistent LLV showing a tendency towards increased risk for multiple health issues.
View Article and Find Full Text PDF

Background: Immune and cognitive dysfunction persists even in virally suppressed women with HIV (VS-WWH). Since inflammation and HIV proteins induce the enzyme indoleamine 2,3-dioxygenase (IDO), converting tryptophan (T) to kynurenine (K) while producing downstream neurotoxic metabolites, we investigated IDO activation (KT ratio) in relation to cognition in VS-WWH and demographically similar women without HIV (WWoH).

Methods: Ninety-nine VS-WWH on stable antiretroviral therapy and 102 WWoH (median age 52 vs 54 years; 73% vs 74% Black, respectively) from the New York and Chicago sites of the Women's Interagency HIV Study (WIHS) completed a neuropsychological test battery assessing motor function, processing speed, attention/working memory, verbal fluency, verbal learning and memory, and executive function and had plasma measured for tryptophan-kynurenine metabolites through liquid chromatography-tandem mass spectrometry and monocyte-derived [soluble cluster of differentiation-14 (sCD14), soluble cluster of differentiation-163 (sCD163), monocyte chemoattractant protein-1 (MCP-1)] plus general inflammatory markers [tumor necrosis factor alpha-2 receptor (TNF-R2), high-sensitivity C-reactive protein, high-sensitivity interleukin-6] through enzyme-linked immunosorbent assays between 2017 and 2020.

View Article and Find Full Text PDF

Objective: The aim of this study was to estimate the longitudinal associations of state-level anti-LGBTQ+ policies and county-level politics with individual HIV prevention outcomes among sexual and gender minoritized (SGM) youth.

Design: Keeping it LITE-1 prospectively enrolled 3330 SGM youth and young adults (ages 13-34) at increased risk of HIV throughout the United States from 2017 to 2022.

Methods: Semiannual surveys collected self-reported HIV prevention measures [current preexposure prophylaxis (PrEP) use, weekly PrEP adherence, HIV/STI testing in the past 6 months].

View Article and Find Full Text PDF

Background: Steatohepatitis is common in persons living with HIV and may be associated with gut microbial translocation (MT). However, few studies have evaluated the gut-liver axis in persons living with HIV. In the Women's Interagency HIV Study, we examined the associations of HIV and circulating biomarkers linked to MT and gut damage using the FibroScan-aspartate aminotransferase (FAST) score, a noninvasive surrogate for steatohepatitis with advanced fibrosis.

View Article and Find Full Text PDF
Article Synopsis
  • Gut dysbiosis, or imbalance in gut bacteria, is linked to diabetes and HIV, but how they interact with metabolic and inflammatory responses in diabetes remains unclear.
  • A study analyzed gut microbial features, metabolites, and inflammatory proteins across a diverse group of women, some with diabetes and HIV, and tracked diabetes development over 12 years in both men and women.
  • Identified bacteria related to diabetes included Shigella and Escherichia, while others like Adlercreutzia showed an inverse relationship; various metabolites and proteins, especially interleukin-18 receptor 1, played roles in mediating these associations.
View Article and Find Full Text PDF

Long COVID (LongC) is associated with a myriad of symptoms including cognitive impairment. We reported at the beginning of the COVID-19 pandemic that neuronal-enriched or L1CAM+ extracellular vesicles (nEVs) from people with LongC contained proteins associated with Alzheimer's disease (AD). Since that time, a subset of people with prior COVID infection continue to report neurological problems more than three months after infection.

View Article and Find Full Text PDF

Sleep disturbances are prevalent in women with HIV (WWH). Tryptophan-kynurenine (T-K) pathway metabolites are associated with alterations in actigraphy derived sleep measures in WWH, although may not always correlate with functional impairment. We investigated the relationship between T-K pathway metabolites and self-reported daytime dysfunction in WWH and women without HIV (WWoH).

View Article and Find Full Text PDF

Many clinical and population-based research studies pivoted from in-person assessments to phone-based surveys due to the COVID-19 pandemic. The impact of these transitions on survey response remains understudied, especially for people living with HIV. Given that there are gender-specific trends in alcohol and substance use, it is particularly important to capture these data for women.

View Article and Find Full Text PDF
Article Synopsis
  • The 2022 monkeypox outbreak mainly affected sexual networks of men who have sex with men (MSM), leading to stigmatizing public health responses focused on abstinence rather than addressing the virus's actual transmission methods.
  • Despite the stigma, a significant percentage of sexual and gender minority youth and young adults (SGM YYA) in Illinois reported being sexually active during the outbreak, with many adopting risk reduction behaviors.
  • The findings suggest that harm reduction and sex-positive messaging may be more effective than abstinence-only approaches, as those vaccinated were more likely to remain sexually active while still adopting protective measures.
View Article and Find Full Text PDF

Objective: Prior epidemic literature suggests that the rapid proliferation of Monkeypox (Mpox) within the United States may trigger severe stress reactions that increase the risk of developing secondary traumatic stress among young adults most at risk of exposure. The present exploratory study aimed to investigate the degree to which proximity to Mpox (i.e.

View Article and Find Full Text PDF

Background: Detection and treatment of anal histologic high-grade squamous intraepithelial lesions (hHSIL) prevents anal cancer. However, anal hHSIL incidence among women with human immunodeficiency virus (HIV, WHIV) remains unknown. Performance of anal high-risk human papillomavirus ([hr]HPV), anal cytology (anal-cyt), and both for hHSIL detection longitudinally over 2 years also remains undetermined.

View Article and Find Full Text PDF

Background: Poor sleep health is an underrecognized health challenge, especially for people with human immunodeficiency virus (HIV). Gut microbiota related to sleep are underinvestigated.

Methods: The IDOze microbiota substudy included 190 women (114 with HIV and 76 without HIV).

View Article and Find Full Text PDF

Importance: Despite aging-related comorbidities representing a growing threat to quality-of-life and mortality among persons with HIV (PWH), clinical guidance for comorbidity screening and prevention is lacking. Understanding comorbidity distribution and severity by sex and gender is essential to informing guidelines for promoting healthy aging in adults with HIV.

Objective: To assess the association of human immunodeficiency virus on the burden of aging-related comorbidities among US adults in the modern treatment era.

View Article and Find Full Text PDF

Introduction: Despite significant improvements in longevity and quality of life associated with antiretroviral therapy, individuals with HIV still suffer from a higher burden of sleep and circadian disruption and inflammatory-based diseases than individuals without HIV. While melatonin is a hormone that has a role in sleep and circadian regulation and has anti-inflammatory properties, the overnight concentration of the urinary melatonin metabolite has not yet been reported in people with HIV.

Methods: The aim of this study was to compare the overnight urinary melatonin metabolite levels in women aged 35-70 years with HIV (n = 151) to a well-matched comparison group of women without HIV (n = 147).

View Article and Find Full Text PDF

Objective: Marijuana, tobacco and alcohol use are prevalent among people with HIV and may adversely affect kidney function in this population. We determined the association of use of these substances with estimated glomerular filtration rate (eGFR) among women with HIV (WWH) and women without HIV.

Design: We undertook a repeated measures study of 1043 WWH and 469 women without HIV within the United States Women's Interagency HIV Study, a multicenter, prospective cohort of HIV-seropositive and HIV-seronegative women.

View Article and Find Full Text PDF

This study examined experiences of healthcare inaccessibility and lesbian, gay, bisexual, transgender, queer, plus (LGBTQ+) discrimination among sexual and gender minority youth at elevated risk for HIV in the United States. Participants for this cross-sectional survey study (= 3330) were cisgender men, transgender men and women, and nonbinary individuals ages 18-34 recruited for a larger study examining HIV risk behavior between December 2017 and December 2019. Results indicated that 41.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how changes in gut microbiota are linked to inflammation and metabolite profiles in relation to atherosclerosis, particularly in women with or at risk of HIV.
  • Researchers found that the bacteria Fusobacterium nucleatum is linked to increased carotid artery plaque, while five other species were inversely related to plaque presence.
  • Furthermore, certain inflammatory markers in the serum were associated with these microbial species, suggesting a complex interplay between gut bacteria, inflammation, and cardiovascular health in the context of HIV.
View Article and Find Full Text PDF

Introduction: The 2022 global outbreak of Monkeypox virus (Mpox), which has primarily spread through the sexual networks of sexual and gender minority (SGM) individuals, has introduced new public health challenges. While an efficacious Mpox vaccine is in active circulation, few Mpox vaccine studies have examined its uptake among SGM groups. The aims of this study were to investigate (a) the prevalence of Mpox vaccine uptake among SGM and (b) the contextual, Mpox-disease specific, and Mpox-vaccine specific factors associated with Mpox vaccine among SGM.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the relationship between tryptophan (TRP) metabolism, gut bacteria, and carotid artery plaque in women, both with and without HIV infection.
  • It assesses various plasma TRP metabolites and their associations with plaque formation, discovering that higher levels of kynurenic acid (KYNA) are linked to increased plaque, while indole-3-propionate (IPA) shows a protective effect.
  • Key gut bacteria associated with IPA were identified, indicating that certain gut microbiome profiles may play a beneficial role in cardiovascular health, particularly in the context of HIV.
View Article and Find Full Text PDF

Integrase strand-transfer inhibitors (INSTIs) are associated with weight gain in women living with HIV (WLH). Relationships between drug exposure, baseline obesity, and INSTI-associated weight gain remain unclear. Data from 2006 to 2016 were analyzed from virally suppressed WLH enrolled in the Women's Interagency HIV Study, who switched/added an INSTI to antiretroviral therapy: [raltegravir (RAL), dolutegravir (DTG), or elvitegravir (EVG)].

View Article and Find Full Text PDF
Article Synopsis
  • Direct-acting antiviral (DAA) therapy for hepatitis C (HCV) is effective and well-received but remains out of reach for many due to cost issues.
  • A study followed women with HIV and HCV to analyze how health insurance status impacted their access to DAA treatment from 2015-2019.
  • Results showed that women with health insurance were significantly more likely to start DAA therapy compared to those without, suggesting that improving insurance coverage could enhance access to HCV treatment for those affected by HIV.
View Article and Find Full Text PDF
Article Synopsis
  • The study explored how menopause affects weight gain in women with HIV (WWH) compared to women without HIV (WWOH), focusing on changes in body mass index (BMI) and waist circumference (WC) from 2000 to 2013.
  • It found that during menopause, WWH experienced a negative change rate in BMI across menopausal phases, while WWOH generally showed positive changes.
  • The results suggest that the menopausal transition leads to less weight gain in WWH, indicating that having HIV may mitigate typical weight gain associated with menopause.
View Article and Find Full Text PDF

Hepatitis D virus (HDV) requires co-infection with hepatitis B virus (HBV). Human immunodeficiency virus (HIV) shares transmission routes with these viruses. Among 4,932 US women infected with or at-risk for HIV during 1994-2015, HBV surface antigen (HBsAg) positivity was more common in women with HIV (2.

View Article and Find Full Text PDF